Depression in Patients with Coronary Heart Disease

American Journal of Medicine

Volumn 121, Issue 11 SUPPL. 2, 2008, Pages

  Carney, Robert M ^a   Freedland, Kenneth E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndromes; Antidepressants; Coronary heart disease; Depression

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

APPETITE; ARTICLE; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HEART PALPITATION; HUMAN; ISCHEMIC HEART DISEASE; LIBIDO; MORBIDITY; MORTALITY; ORTHOSTATIC HYPOTENSION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; QT INTERVAL; QUALITY OF LIFE; RISK FACTOR; SCREENING; SIDE EFFECT; SOMNOLENCE; SWEATING; TACHYCARDIA;

ANTIDEPRESSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIALS AS TOPIC; CORONARY DISEASE; CYTOKINES; DEPRESSION; EXERCISE; HUMANS; MASS SCREENING; PATIENT COMPLIANCE; PROGNOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS;

EID: 54049155775     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.08.006     Document Type: Article

References (115)

1. American Heart Association. Coronary Heart Disease and Angina Pectoris-2002 Heart and Stroke Statistical Update (2001), American Heart Association, Dallas, TX
2. Carney R.M., Rich M.W., teVelde A., Saini J., Clark K., and Jaffe A.S. Major depressive disorder in coronary artery disease. Am J Cardiol. 60 (1987) 1273-1275
3. Gonzalez M.B., Snyderman T.B., Colket J.T., et al. Depression in patients with coronary artery disease. Depression 4 (1996) 57-62
4. Hance M., Carney R.M., Freedland K.E., and Skala J. Depression in patients with coronary heart disease: a 12-month follow-up. Gen Hosp Psychiatry 18 (1996) 61-65
5. Carney R.M., Freedland K.E., and Jaffe A.S. Insomnia and depression prior to myocardial infarction. Psychosom Med. 52 (1990) 603-609
6. Forrester A.W., Lipsey J.R., Teitelbaum M.L., DePaulo J.R., and Andrzejewski P.L. Depression following myocardial infarction. Int J Psychiatry Med. 22 (1992) 33-46
7. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 270 (1993) 1819-1825
8. Schleifer S.J., Macari-Hinson M.M., Coyle D.A., et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 149 (1989) 1785-1789
9. Travella J.I., Forrester A.W., Schultz S.K., and Robinson R.G. Depression following myocardial infarction: a one year longitudinal study. Int J Psychiatry Med. 24 (1994) 357-369
10. Beck C.A., Joseph L., Belisle P., and Pilote L. Predictors of quality of life 6 months and 1 year after acute myocardial infarction. Am Heart J 142 (2001) 271-279
11. Cay E.L., Vetter N., Philip A.E., and Dugard P. Psychological status during recovery from an acute heart attack. J Psychosom Res. 16 (1972) 425-435
12. Ladwig K.H., Roll G., Breithardt G., Budde T., and Borggrefe M. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 343 (1994) 20-23
13. Lane D., Carroll D., Ring C., Beevers D.G., and Lip G.Y. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res. 51 (2001) 497-501
14. Lloyd G.G., and Cawley R.H. Distress or illness?. A study of psychological symptoms after myocardial infarction. Br J Psychiatry 142 (1983) 120-125
15. Mayou R., Foster A., and Williamson B. Psychosocial adjustment in patients one year after myocardial infarction. J Psychosom Res. 22 (1978) 447-453
16. Parashar S., Rumsfeld J.S., Spertus J.A., et al. Time course of depression and outcome of myocardial infarction. Arch Intern Med. 166 (2006) 2035-2043
17. Soderman E., Lisspers J., and Sundin O. Depression as a predictor of return to work in patients with coronary artery disease. Soc Sci Med. 56 (2003) 193-202
18. Barefoot J.C., Helms M.J., Mark D.B., et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 78 (1996) 613-617
19. Carney R.M., Rich M.W., Freedland K.E., et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 50 (1988) 627-633
20. Herrmann C., Brand-Driehorst S., Buss U., and Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res. 48 (2000) 455-462
21. Blumenthal J.A., Lett H.S., Babyak M.A., et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362 (2003) 604-609
22. Burg M.M., Benedetto C.M., Rosenberg R., and Soufer R. Depression prior to CABG predicts 6-month and 2-year morbidity and mortality [abstract]. Psychosom Med. 63 (2001) 103
23. Connerney I., Shapiro P.A., McLaughlin J.S., and Sloan R.P. In-hospital depression after CABG surgery predicts 12-month outcome [abstract]. Psychosom Med. 62 (2000) 106
24. Ahern D.K., Gorkin L., Anderson J.L., et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol. 66 (1990) 59-62
25. Bush D.E., Ziegelstein R.C., Tayback M., et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 88 (2001) 337-341
26. Denollet J., Sys S.U., and Brutsaert D.L. Personality and mortality after myocardial infarction. Psychosom Med. 57 (1995) 582-591
27. Frasure-Smith N., Lesperance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995) 999-1005
28. Irvine J., Basinski A., Baker B., et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med. 6 (1999) 729-737
29. Kaufmann M.W., Fitzgibbons J.P., Sussman E.J., et al. Relation between myocardial infarction, depression, hostility, and death. Am Heart J 138 pt 1 (1999) 549-554
30. Ladwig K.H., Kieser M., Konig J., Breithardt G., and Borggrefe M. Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur Heart J. 12 (1991) 959-964
31. van Melle J.P., de Jonge P., Spijkerman T.A., et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 66 (2004) 814-822
32. Lesperance F., Frasure-Smith N., Juneau M., and Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 160 (2000) 1354-1360
33. Carney R.M., and Freedland K.E. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 54 (2003) 241-247
34. Carney R.M., Blumenthal J.A., Catellier D., et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol. 92 (2003) 1277-1281
35. Carney R.M., Freedland K.E., Miller G.E., and Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 53 (2002) 897-902
36. Carney R.M., Freedland K.E., and Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med. 67 suppl 1 (2005) S29-S33
37. Bigger Jr. J.T., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., and Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 85 (1992) 164-171
38. Kleiger R.E., Miller J.P., Bigger Jr. J.T., and Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59 (1987) 256-262
39. Rich M.W., Saini J.S., Kleiger R.E., Carney R.M., teVelde A., and Freedland K.E. Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol. 62 pt 1 (1988) 714-717
40. Vaishnav S., Stevenson R., Marchant B., Lagi K., Ranjadayalan K., and Timmis A.D. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol. 73 (1994) 653-657
41. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93 (1996) 1043-1065
42. Kliks B.R., Burgess M.J., and Abildskov J.A. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol. 36 (1975) 45-49
43. Podrid P.J., Fuchs T., and Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 82 suppl (1990) I103-I113
44. Schwartz P.J., and Vanoli E. Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. J Cardiovasc Pharmacol. 3 (1981) 1251-1259
45. Gehi A., Mangano D., Pipkin S., Browner W.S., and Whooley M.A. Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry 62 (2005) 661-666
46. Carney R.M., Blumenthal J.A., Stein P.K., et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001) 2024-2028
47. Carney R.M., Rich M.W., teVelde A., Saini J., Clark K., and Freedland K.E. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res. 32 (1988) 159-164
48. Carney R.M., Saunders R.D., Freedland K.E., Stein P., Rich M.W., and Jaffe A.S. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 76 (1995) 562-564
49. Guinjoan S.M., de Guevara M.S., Correa C., et al. Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes. J Psychosom Res. 56 (2004) 83-88
50. Krittayaphong R., Cascio W.E., Light K.C., et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med. 59 (1997) 231-235
51. Stein P.K., Carney R.M., Freedland K.E., et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res. 48 (2000) 493-500
52. van den Berg M.P., Spijkerman T.A., van Melle J.P., et al. Depression as an independent determinant of decreased heart rate variability in patients post myocardial infarction. Neth Heart J. 13 (2005) 165-169
53. Carney R.M., Freedland K.E., Veith R.C., et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 45 (1999) 458-463
54. Carney R.M., Freedland K.E., Stein P.K., et al. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med. 65 (2003) 177-180
55. Carney R.M., Howells W.B., Blumenthal J.A., et al. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med. 69 (2007) 4-9
56. Dentino A.N., Pieper C.F., Rao M.K., et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 47 (1999) 6-11
57. Kop W.J., Gottdiener J.S., Tangen C.M., et al. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 89 (2002) 419-424
58. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., and Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9 (1997) 853-858
59. Miller G.E., Freedland K.E., Carney R.M., Stetler C.A., and Banks W.A. Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med. 26 (2003) 501-515
60. Miller G.E., Freedland K.E., Carney R.M., Stetler C.A., and Banks W.A. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 17 (2003) 276-285
61. Miller G.E., Freedland K.E., Duntley S., and Carney R.M. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 95 (2005) 317-321
62. Shimbo D., Chaplin W., Crossman D., Haas D., and Davidson K.W. Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol. 96 (2005) 1016-1021
63. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
64. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
65. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342 (2000) 836-843
66. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., and Braunwald E. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
67. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
68. Fitzgerald D.J., Roy L., Catella F., and FitzGerald G.A. Platelet activation in unstable coronary disease. N Engl J Med. 315 (1986) 983-989
69. Trip M.D., Cats V.M., van Capelle F.J., and Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 322 (1990) 1549-1554
70. Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., and Finkel M.S. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 42 (1997) 290-295
71. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 153 (1996) 1313-1317
72. von Kanel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?. Acta Psychiatr Scand. 110 (2004) 163-177
73. Broadley A.J., Korszun A., Jones C.J., and Frenneaux M.P. Arterial endothelial function is impaired in treated depression. Heart 88 (2002) 521-523
74. Rajagopalan S., Brook R., Rubenfire M., Pitt E., Young E., and Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. [published correction appears in Am J Cardiol. 2001;88:722]. Am J Cardiol. 88 (2001) 196-198 A7
75. Rybakowski J.K., Wykretowicz A., Heymann-Szlachcinska A., and Wysocki H. Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry 60 (2006) 889-891
76. Sherwood A., Hinderliter A.L., Watkins L.L., Waugh R.A., and Blumenthal J.A. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 46 (2005) 656-659
77. Skala J.A., Freedland K.E., and Carney R.M. Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry 51 (2006) 738-745
78. Gehi A., Haas D., Pipkin S., and Whooley M.A. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 165 (2005) 2508-2513
79. Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., and Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 14 (1995) 88-90
80. Rieckmann N., Gerin W., Kronish I.M., et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol. 48 (2006) 2218-2222
81. Dickens C.M., Percival C., McGowan L., et al. The risk factors for depression in first myocardial infarction patients. Psychol Med. 34 (2004) 1083-1092
82. Lesperance F., Frasure-Smith N., and Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med. 58 (1996) 99-110
83. Mallik S., Spertus J.A., Reid K.J., et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med. 166 (2006) 876-883
84. Spijkerman T.A., van den Brink R.H., Jansen J.H., Crijns H.J., and Ormel J. Who is at risk of post-MI depressive symptoms?. J Psychosom Res. 58 (2005) 425-432 discussion 433-434
85. Davidson K.W., Kupfer D.J., Bigger J.T., et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Ann Behav Med. 32 (2006) 121-126
86. Beck A.T., Rush A.J., Shaw B.F., and Emery G. Cognitive Therapy of Depression (1979), Guilford Press, New York
87. Shores M.M., Pascualy M., and Veith R.C. Major depression and heart disease: treatment trials. Semin Clin Neuropsychiatry 3 (1998) 87-101
88. Sheline Y.I., Freedland K.E., and Carney R.M. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?. Am J Med. 102 (1997) 54-59
89. Strik J.J., Honig A., Lousberg R., et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med. 62 (2000) 783-789
90. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
91. Lesperance F., Frasure-Smith N., Koszycki D., et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 297 (2007) 367-379
92. Honig A., Kuyper A.M., Schene A.H., et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med. 69 (2007) 606-613
93. Venlafaxine. [package insert] (1999), Wyeth Pharmaceuticals, Philadelphia
94. Johnson E.M., Whyte E., Mulsant B.H., et al. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry 14 (2006) 796-802
95. Kokan L., and Dart R. Life-threatening hypotension from venlafaxine overdose [abstract]. Ann Emerg Med. 27 (1996) 815
96. Lessard E., Yessine M.A., Hamelin B.A., O'Hara G., LeBlanc J., and Turgeon J. Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans. Pharmacogenetics 9 (1999) 435-443
97. Peano C., Leikin J.B., and Hanashiro P.K. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med. 30 (1997) 704-708
98. Tonstad S., Farsang C., Klaene G., et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J 24 (2003) 946-955
99. Rigotti N.A., Thorndike A.N., Regan S., et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med. 119 (2006) 1080-1087
100. Klerman G.L. Interpersonal Psychotherapy of Depression (1984), Basic Books, New York
101. Murphy G.E., Simons A.D., Wetzel R.D., and Lustman P.J. Cognitive therapy and pharmacotherapy: singly and together in the treatment of depression. Arch Gen Psychiatry 41 (1984) 33-41
102. Murphy G.E., Carney R.M., Knesevich M.A., Wetzel R.D., and Whitworth P. Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychol Rep. 77 (1995) 403-420
103. Markowitz J.C., Klerman G.L., and Perry S.W. Interpersonal psychotherapy of depressed HIV-positive outpatients. Hosp Community Psychiatry 43 (1992) 885-890
104. Elkin I., Shea M.T., Watkins J.T., et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 46 (1989) 971-982 discussion 983
105. Mossey J.M., Knott K.A., Higgins M., and Talerico K. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci. 51 (1996) M172-M178
106. Schulberg H.C., Scott C.P., Madonia M.J., and Imber S.D. Applications of interpersonal psychotherapy to depression in primary care practice. In: Klerman G.L., and Weissman M.M. (Eds). New Applications of Interpersonal Psychotherapy. 1st ed. (1993), American Psychiatric Press, Washington, DC 265-291
107. Skala J.A., Freedland K.E., and Carney R.M. Heart Disease Vol 2 (2005), Hogrefe & Huber Publishers, Cambridge, MA
108. Hegel M.T., Barrett J.E., Cornell J.E., and Oxman T.E. Predictors of response to problem-solving treatment of depression in primary care. Behav Ther. 33 (2002) 511-527
109. Martell C.R., Addis M.E., and Jacobson N.S. Depression in Context: Strategies for Guided Action (2001), Norton, New York
110. Blumenthal J.A., Babyak M.A., Doraiswamy P.M., et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 69 (2007) 587-596
111. Milani R.V., and Lavie C.J. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med. 120 (2007) 799-806
112. Berkman L.F., Blumenthal J., Burg M., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289 (2003) 3106-3116
113. van Melle J.P., de Jonge P., Honig A., et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 190 (2007) 460-466
114. Taylor C.B., Youngblood M.E., Catellier D., et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62 (2005) 792-798
115. Ormel J. Synchrony of change in depression and disability: what next?. Arch Gen Psychiatry 57 (2000) 381-382